Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS)

CUSIP: N69605108

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Ordinary Shares, Euro 0.12 par value per share
Shares outstanding
65,632,680
Total 13F shares
44,644,168
Share change
-409,540
Total reported value
$855,824,077
Price per share
$19.17
Number of holders
54
Value change
-$7,190,155
Number of buys
24
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP N69605108?
CUSIP N69605108 identifies PHVS - Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) as of Q4 2024

As of 31 Dec 2024, Pharvaris N.V. - Ordinary Shares, Euro 0.12 par value per share (PHVS) was held by 54 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,644,168 shares. The largest 10 holders included GENERAL ATLANTIC, L.P., FMR LLC, Foresite Capital Management IV, LLC, venBio Partners LLC, VIKING GLOBAL INVESTORS LP, Bain Capital Life Sciences Investors, LLC, VR Adviser, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), COMMODORE CAPITAL LP, and Novo Holdings A/S. This page lists 54 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.